Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2019 at 7:32 PM.

  1. #1 cafead, May 17, 2019 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Dow Jones component Johnson & Johnson (JNJ) could buy out biotech stock MeiraGTx (MGTX) for its efforts in gene therapy, an analyst suggested Friday.

    article source
     
    Quote

Reply to Thread